GNMSF:OTCMKTS
Genmab
US$ 367.00
0.00%
(0.00) Siku 1
9 Okt, 10:28:36 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya GNMSF...
Mtaji wa soko
22.76B
Wastani wa kiasi cha mauzo
elfu 1.37
Kiasi cha mauzo ya hisa
180.00
Juu kwa wiki 52
US$ 396.97
Chini kwa wiki 52
US$ 232.50
Beta
0.73
Hisa za wawekezaji
62.41M
Idadi ya wafanyakazi
elfu 3
Mtaji wa soko
22.76B
Wastani wa kiasi cha mauzo
elfu 1.37
Kiasi cha mauzo ya hisa
180.00
Juu kwa wiki 52
US$ 396.97
Chini kwa wiki 52
US$ 232.50
Beta
0.73
Hisa za wawekezaji
62.41M
Idadi ya wafanyakazi
elfu 3
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
TipRanks
·
saa 18 zilizopita
Genmab Reports USD 4.2 Billion in Q3 2026 DARZALEX Net Sales
Wasifu
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Kuhusu Genmab
Afisa Mkuu Mtendaji (CEO)Jan G. J. van de Winkel
Wafanyakazielfu 3.12
Lilianzishwa11 Jun 1998
Makao makuu-
Sekta-
Tovutigenmab.com